Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iMETX (Individualized Metabolic RX): a Pilot Study of an Environmental Intervention to Increase Energy Expenditure Among Breast Cancer Survivors

NCT03158519 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT03158519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03158519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iMETX (Individualized Metabolic RX): a Pilot Study of an Environmental Intervention to Increase Energy Expenditure Among Breast Cancer Survivors
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2017
Completion date
April 1, 2019
Enrollment
64 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer